⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Official Title: PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Study ID: NCT01617954

Interventions

MammaPrint

Study Description

Brief Summary: This is a prospective study that will assess the impact of MammaPrint on chemotherapy + endocrine versus endocrine alone treatment decisions in patients with an Oncotype Intermediate Score.

Detailed Description: The frequency of chemotherapy + endocrine versus endocrine alone decisions in Oncotype DX intermediate score patients will be calculated before and after receiving the MammaPrint result.

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Maricopa Integrated Health System, Phoenix, Arizona, United States

Providence Saint Joseph Medical Center, Burbank, California, United States

Comprehensive Cancer Center, Palm Springs, California, United States

Breastlink, Santa Ana, California, United States

Redwood Regional Cancer Center, Santa Rosa, California, United States

Exempla Saint Joseph Hospital, Denver, Colorado, United States

Stamford Hospital, Stamford, Connecticut, United States

The Breast Institute at JFK Medical, Atlantis, Florida, United States

Halifax Health Center for Oncology, Daytona Beach, Florida, United States

Broward Health Medical Center, Fort Lauderdale, Florida, United States

Regional Breast/21st Century Oncology, Fort Myers, Florida, United States

Northeast Georgia Cancer Care, Athens, Georgia, United States

Dekalb Medical Center, Decatur, Georgia, United States

Northeast Georgia Medical Center, Gainesville, Georgia, United States

Loyola University Medical Center, Chicago, Illinois, United States

Alexian Brothers Medical Center, Elk Grove Village, Illinois, United States

Delnor Community Hospital, Geneva, Illinois, United States

Ingalls Memorial Hospital, Harvey, Illinois, United States

Orchard Healthcare Research, Northbrook, Illinois, United States

CDH Cancer Center, Winfield, Illinois, United States

IU Health Bloomington, Bloomington, Indiana, United States

Northern Indiana Cancer Research Consortium, South Bend, Indiana, United States

Covenant Medical Center, Waterloo, Iowa, United States

MedStar Harbor Hospital, Baltimore, Maryland, United States

Harry & Jeanette Weinberg Cancer Institute at Franklin Square, Baltimore, Maryland, United States

Mercy Medical Center, Baltimore, Maryland, United States

Western Maryland Health System, Cumberland, Maryland, United States

Lahey Clinic, Burlington, Massachusetts, United States

Mount Auburn Hospital, Cambridge, Massachusetts, United States

MetroWest Medical Center, Framingham, Massachusetts, United States

St. Vincent Hospital, Worcester, Massachusetts, United States

Detroit Clinical Research Center, Detroit, Michigan, United States

Virginia Piper Cancer Institute, Minneapolis, Minnesota, United States

St. Louis Cancer Care, Bridgeton, Missouri, United States

SSM Cancer Center, St. Louis, Missouri, United States

Roswell Park Cancer Center, Buffalo, New York, United States

North Shore/Monter Cancer Center, Lake Success, New York, United States

Columbia University, New York, New York, United States

University of Oklahoma, Oklahoma City, Oklahoma, United States

Tulsa Cancer Institute, Tulsa, Oklahoma, United States

St. Mary Medical Center, Langhorne, Pennsylvania, United States

St. Clair Hospital, Pittsburgh, Pennsylvania, United States

Charleston Cancer Center, Charleston, South Carolina, United States

Cookeville Regional Medical Center, Cookeville, Tennessee, United States

Knoxville Comprehensive Breast Center, Knoxville, Tennessee, United States

Nashville Breast Center, Nashville, Tennessee, United States

Texas Health, Dallas, Texas, United States

Hematology/Oncology Associates, Alexandria, Virginia, United States

Lynchburg Hematology Oncology Clinic, Lynchburg, Virginia, United States

Swedish Cancer Institute, Seattle, Washington, United States

Columbia St. Mary's Cancer Center, Milwaukee, Wisconsin, United States

Aurora Advanced Healthcare, Milwaukee, Wisconsin, United States

Wheaton Franciscan Cancer Care - All Saints, Racine, Wisconsin, United States

Contact Details

Name: Michaela Tsai, MD

Affiliation: Piper Breast Center

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: